Hybrigenics’ inhibitor of Ubiquitin-Specific Protease 7 (USP7) shows activity in preclinical models of Chronic Lymphocytic Leukemia (CLL)

To subscribe to Press releases from this issuer, visit the Subscription to Company news section in your account section or create an account.